Back to the main directory
EarningsReview / Equity
- Itaú BBA on JSL: Notes From 1Q25 Conference Call by Itau
- Strong 2025 outlook - increase in growth spending by BNP Paribas
- 1Q25 results - A solid start of the year by BNP Paribas
- Q125 results: strong by BNP Paribas
- Sydbank - NII sensitivity is known – what about fee strength? by Danske Bank Equity Research
- Q1 reassures after recent share price weakness by BNP Paribas
- Q125 conf call: some caution on Q2 by BNP Paribas
- A Grand Opening to ‘25 (& Questions for mgmt.) by BNP Paribas
- DNB - Hats off to a great quarter by Danske Bank Equity Research
- PCIM feedback by BNP Paribas
- Top line delivery continues by BNP Paribas
- Bank of Baroda (BOB IN) by HSBC
- Good margin, 2025 targets almost achieved by BNP Paribas
- EBITDA beat, driven by Biedronka margins; -3.5% LFL a drag though by BNP Paribas
- 1Q25 miss, but reiterates guidance by BNP Paribas
- 1Q25 results confirm preliminaries, Q2 sales/EPS guidance 3%/4% above consensus, stronger focus on shareholder returns by BNP Paribas
- 3Q25 revenue miss and adj. EPS beat by BNP Paribas
- Norwegian Air Shuttle (Buy, TP: NOK17.00) - April traffic statistics by DnB Markets
- Peab (Hold, TP: SEK85.00) - Q1 EBIT broadly as expected by DnB Markets
- Aker BP (Buy, TP: NOK280.00) - Well-supported dividends by DnB Markets
- Sampo Oyj (Buy, TP: EUR10.20) - Strong underwriting momentum by DnB Markets
- Schibsted (Sell, TP: NOK290.00) - Muted growth continues by DnB Markets
- Axactor (Hold, TP: NOK5.90) - Collection rebound by DnB Markets
- Elopak (Hold, TP: NOK44.00) - A quarter without surprises by DnB Markets
- DNB (No_rec, TP: NOK) - Higher fees and improved capital outlook by DnB Markets
- Storebrand - Temporary casualty of the expectations treadmill by Danske Bank Equity Research
- What's the big deal? April edition by BNP Paribas
- Concerns linger despite the 4Q beat by BNP Paribas
- Loomis - Onwards and upwards by Danske Bank Equity Research
- Ambu - Asian Ambu(sh) appears temporary by Danske Bank Equity Research
- Orsted 1Q25 conference call key points & views by BNP Paribas
- Expect a recovery in sales growth, margins in FY26 by BNP Paribas
- Solid FY25 but headwinds loom by BNP Paribas
- A strong start to 2025, but tariff headwinds loom by BNP Paribas
- Adjusting estimates post Q1 by BNP Paribas
- UOB Ltd (UOB SP) by HSBC
- Integrating Anima after a solid 1Q25 by BNP Paribas
- Q125 results and 15 questions for management by BNP Paribas
- Non material data changes by BNP Paribas
- Q1 a significant beat on margins + good cashflow by BNP Paribas
- Q1 miss and US FY guidance downgraded on sports results by BNP Paribas
- Q1 2025 First take by BNP Paribas
- Hiab (Buy, TP: EUR50.00) - Earnings shine by DnB Markets
- Lundbeck (Buy, TP: DKK48.00) - Focus on Vyepti sales by DnB Markets
- Storebrand (Buy, TP: NOK149.00) - Insurance repricing on track by DnB Markets
- Novo Nordisk (Buy, TP: DKK900.00) - Accelerated Wegovy roll-out ahead by DnB Markets
- Gentian Diagnostics (Buy, TP: NOK67.00) - Strong start to 2025 by DnB Markets
- Tomra (Sell, TP: NOK130.00) - Disappointing Recycling orders by DnB Markets
- Skanska (Buy, TP: SEK255.00) - Volatile miss in Q1 by DnB Markets
- Sats (Hold, TP: NOK37.00) - Time for a breather by DnB Markets